10X Fund, L.P. - 22 Oct 2025 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
10%+ Owner
Signature
/s/ James C. Czirr, as Managing Member of the General Partner for 10X Fund, LP
Issuer symbol
GALT
Transactions as of
22 Oct 2025
Transactions value $
-$246,800
Form type
4
Date filed
24 Oct 2025, 20:18
Previous filing
10 Oct 2025
Next filing
04 Dec 2025

Reporting Owners (3)

Name Relationship Address Signature Signature date CIK
10X Fund, L.P. 10%+ Owner 545 DUTCH VALLEY ROAD, N.E., SUITE A, ATLANTA, /s/ James C. Czirr, as Managing Member of the General Partner for 10X Fund, LP 2025-10-23 0001453356
10X Capital Management, LLC 10%+ Owner 545 DUTCH VALLEY ROAD, N.E., SUITE A, ATLANTA, /s/ James C. Czirr, as Managing Member of 10X Capital Management, LLC 2025-10-23 0001457247
CZIRR JAMES C 10%+ Owner 4908 SOUTH ASHTON COURT, SPOKANE /s/ James C. Czirr, Individually 2025-10-23 0001260641

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Sale -$98.6K -20K -0.34% $4.93 5.9M 22 Oct 2025 Direct F1
transaction GALT Common Stock Sale -$148K -30K -0.51% $4.94 5.87M 22 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.